Psychedelic healthcare and PTSD
It is estimated 15 million people suffer from PTSD each year, with wide-reaching socioeconomic consequences.
Many of those afflicted are ex-armed forces and emergency services personnel, with SSRIs typically the frontline treatment.
However, many patients do not respond to these medications and, as a result, go untreated – developing comorbidities such as major depressive disorder, substance abuse and suicidality.
When conventional treatments fail, Heroic Hearts UK connects British veterans with PTSD to psychedelic-assisted therapy services around the world.
CEO Keith Abraham will be joining industry leaders at the PSYCH Symposium on Wednesday 11 May, to share insights from the organisation’s extraordinary work.READ MORE